as 02-21-2025 3:35pm EST
Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.
Founded: | 2010 | Country: | United States |
Employees: | 827 | City: | SAN FRANCISCO |
Market Cap: | 13.6B | IPO Year: | 2021 |
Target Price: | $63.63 | AVG Volume (30 days): | 3.1M |
Analyst Decision: | Buy | Number of Analysts: | 16 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 1.00 | EPS Growth: | 49.41 |
52 Week Low/High: | $22.96 - $85.21 | Next Earning Date: | 02-06-2025 |
Revenue: | $550,168,000 | Revenue Growth: | 17.47% |
Revenue Growth (this year): | 15.85% | Revenue Growth (next year): | 10.43% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Yang Watkin Phoebe L. | DOCS | Director | Feb 12 '25 | Sell | $75.19 | 2,889 | $217,209.47 | 14,729 | |
Wampler Kira Scherer | DOCS | Director | Feb 11 '25 | Sell | $77.81 | 2,000 | $154,385.05 | 17,485 | |
Benjamin Regina M. | DOCS | Director | Feb 11 '25 | Sell | $77.12 | 40,000 | $3,045,882.71 | 26,827 | |
Bryson Anna | DOCS | Chief Financial Officer | Feb 11 '25 | Sell | $77.11 | 95,000 | $7,224,790.35 | 408,231 | |
Cabral Timothy S | DOCS | Director | Feb 3 '25 | Sell | $57.64 | 20,000 | $1,152,498.32 | 24,096 |
DOCS Breaking Stock News: Dive into DOCS Ticker-Specific Updates for Smart Investing
Insider Monkey
18 hours ago
Insider Monkey
3 days ago
Argus Research
3 days ago
Zacks
5 days ago
Insider Monkey
8 days ago
Argus Research
8 days ago
Business Wire
8 days ago
Zacks
10 days ago
The information presented on this page, "DOCS Doximity Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.